Posttraumatic Stress Disorder
📧 Sign up to get email alerts when something new happens for Posttraumatic Stress Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-10-06Clinical Trial Update: GAMBIT Task With PTSD and Healthy Control Participants [NA]
The GAMBIT Task study involving participants with posttraumatic stress disorder and healthy controls was terminated; no results are reported…
-
CLINICAL_TRIALS withdrawal · 2025-07-08Clinical Trial Update: Telehealth-Massed Imaginal Exposure for PTSD [NA]
A clinical trial investigating telehealth imaginal exposure therapy for Posttraumatic Stress Disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-23Clinical Trial Update: Administration of Prazosin to Prevent PTSD in Adult Women After Sexual Assault [Phase 4]
A Phase 4 trial evaluating the use of prazosin to prevent posttraumatic stress disorder in adult women after sexual assault was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-13Clinical Trial Update: Gaze-Contingent Music Reward Treatment for PTSD [NA]
A clinical trial evaluating gaze-contingent music reward treatment for posttraumatic stress disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-24Clinical Trial Update: Intervention Evaluation WEH (Women Who Have Experienced Homelessness) [Phase 1]
A Phase 1 trial evaluating an intervention for posttraumatic stress disorder in women who have experienced homelessness has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-11-01Clinical Trial Update: Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD [Phase 2]
A Phase 2 study assessing MDMA-assisted therapy for Posttraumatic Stress Disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-24Clinical Trial Update: TDCS-Augmented Prolonged Exposure Therapy [NA]
The clinical trial evaluating TDCS-augmented prolonged exposure therapy for PTSD has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-03-24Clinical Trial Update: Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept [Phase 4]
A Phase 4 trial of pimavanserin for insomnia in veterans with PTSD was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-04-02Clinical Trial Update: Couples-based Behavioral Psychotherapy for Male Patients With Posttraumatic Stress Disorder and Alcohol Dependence [Phase 2, Phase 3]
A clinical trial evaluating couples-based behavioral psychotherapy for men with PTSD and alcohol dependence was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: Study of Quality of Life in Freeman-Sheldon Syndrome and Related Conditions
This clinical trial update notes that the study evaluating quality of life in Freeman-Sheldon syndrome and related conditions has been termi…
-
CLINICAL_TRIALS withdrawal · 2016-08-23Clinical Trial Update: Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD) [Phase 4]
A Phase 4 trial evaluating paliperidone for posttraumatic stress disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-01-13Clinical Trial Update: Results From a 24 Week Trial of EMDR Combined With Venlafaxine XR [Phase 4]
A Phase 4 trial evaluating EMDR combined with venlafaxine XR for posttraumatic stress disorder was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-09-23Clinical Trial Update: Effect of Prazosin on Neurophysiology and Cognition in Post-Traumatic Stress Disorder (PTSD) [NA]
The clinical trial evaluating prazosin for neurophysiology and cognition in post-traumatic stress disorder has been withdrawn.